Distributed automated manufacturing of pluripotent stem cell products

Establishing how to effectively manufacture cell therapies is an industry-level problem. Decentralised manufacturing is of increasing importance, and its challenges are recognised by healthcare regulators with deviations and comparability issues receiving specific attention from them. This paper is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Adv Manuf Technol
Main Authors: Shariatzadeh, Maryam, Chandra, Amit, Wilson, Samantha L, McCall, Mark J, Morizur, Lise, Lesueur, Léa, Chose, Olivier, Gepp, Michael M., Schulz, André, Neubauer, Julia C., Zimmermann, Heiko, Abranches, Elsa, Man, Jennifer, O’Shea, Orla, Stacey, Glyn, Hewitt, Zoe, Williams, David J
Formato: Artigo
Idioma:Inglês
Publicado em: Springer London 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954896/
https://ncbi.nlm.nih.gov/pubmed/31983799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00170-019-04516-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados